Agile Therapeutics to Present at Upcoming March Investor Conferences
March 05 2021 - 7:30AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced that Chairman and Chief Executive Officer
Al Altomari will present at two investor conferences in March.
- H.C. Wainwright Global Life Sciences
Conference
- On demand beginning Tuesday, March 9, 2021 at 7:00 a.m.
ET
- Oppenheimer 31st Annual Virtual Healthcare
Conference
- Wednesday, March 17, 2021 at 8:40 a.m. ET
Presentations from each conference will be webcast on the
Investors section of the Agile Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
Each archived webcast will be available for 30 days.
About Agile Therapeutics, Inc.Agile
Therapeutics is a forward-looking women's healthcare company
dedicated to fulfilling the unmet health needs of today’s
women. Our product and product candidates are designed to
provide women with contraceptive options that offer freedom from
taking a daily pill, without committing to a longer-acting
method. Our initial product, Twirla®, (levonorgestrel and
ethinyl estradiol), a transdermal system, is a non-daily
prescription contraceptive. Twirla is based on our proprietary
transdermal patch technology, called Skinfusion®, which is designed
to allow drug delivery through the skin. For more information,
please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Contact: Matt RileyHead of Investor
Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024